Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

about

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

Item

http://www.wikidata.org/entity/Q42200748

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@en

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@nl

type

Item

label

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@en

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@nl

prefLabel

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@en

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@nl

P1476

Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease.

@en

P2093

Birsel Ekici

http://www.w3.org/2001/XMLSchema#string

Emre Erbabacan

http://www.w3.org/2001/XMLSchema#string

Fatiş Altindaş

http://www.w3.org/2001/XMLSchema#string

Güniz M Köksal

http://www.w3.org/2001/XMLSchema#string

Tuğçe Barça Şeker

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.

Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.

Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.

Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.

Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies.

Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives.

Do we need to use sugammadex at the end of a general anesthesia to reverse the action of neuromuscular bloking agents? Position Paper on Sugammadex use.

Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.

Excess comorbidities associated with malignant hyperthermia diagnosis in pediatric hospital discharge records.

Perioperative care of a child with Ullrich congenital muscular dystrophy.

P304

356-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.5152/TJAR.2015.22448

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rahsan Ozcan

P577

2015-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27366528

http://www.w3.org/2001/XMLSchema#string

P932

4894239

http://www.w3.org/2001/XMLSchema#string